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Introduction
The goal of this proposal was to develop an ex vivo/in vivo experimental system to test whether: (i). a mutator phenotype is sufficient to accelerate neoplastic transformation of an immortalized breast epithelial cell line, and (ii). a mutator phenotype is sufficient to accelerate malignant progression of a neoplastic cell line. In this approach, overexpression of variant mutator forms of DNA polymerase B (polB) was proposed to act as a surrogate means of generating genetic diversity. Pol B is the major DNA synthesizing enzyme in base excision repair (BER). DNA lesions resulting from normal cellular metabolism contribute to spontaneous mutations, and are removed by the BER pathway. We hypothesized that intracellular overexpression of wild-type and variant polB enzymes would increase the level of spontaneous mutagenesis, and result in random mutations of oncogene and tumor suppressor loci in epithelial cells. Our long-term goal is to utilize this system to elucidate the role in breast cancer development of various endogenous conditions which may contribute to genetic instability, such as estrogen metabolism and oxidative stress, both of which form DNA adducts repaired by the BER pathway. This avenue of research is vital to understanding oncogenesis in the majority of sporadic human breast cancers, the etiology of which is not associated with familial genetic defects or gross exposures to environmental chemicals. 
L.A. Establishment of MCF10A and MCF-10AT cell culture.
Ex vivo cell cultures for the MCF-1 OA and MCF-1 OAT cell lines were established. We obtained cells from the laboratory of Dr. Danny Welch, co-investigator on this project. We routinely culture the cell lines using published media constituents (Soule et al., 1990) : DMEM/F12 media supplemented with 5% horse serum, 10 pg/ml insulin, 10 ng/ml EGF, 0.5 pg/ml hydrocortisone, and 100 ng/ml cholera toxin. Photographs of confluent cultures of each cell line are shown in Figure 1 . The ras-transfected MCF-10AT cells display the loss of contact inhibition growth patterns expected for a transformed cell line.
MCFIOA cells
MCF1OAT cells Figure 1 . Bright field photographs of parental cell lines used in this study. (Opresko et al, 2002) into two human cell expression vectors ( Figure 2 . vector, and has been used in all Figure 2 . poiB expression vectors for MCF-10A!AT cells. subsequent experiments included in this Final Report. We proposed to use the expression of variant forms of polf3 as internal "generators" of genetic diversity. The pollB variants Y265W and Y265S have been shown to produce frameshift and base substitution errors at an increased rate, relative to wild-type polB, in an in vitro system (Opresko et al, 2002) . Three forms of the pIRES/polB vector were created for use in the MCF-I OA/AT cell system: wild-type (WT), Y265W and R253M.
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B. 1.2 Attempts to construct a polfl gene cassette.
Our progress towards creating the epitope-tagged polB expression vectors shown in Figure 2 was slowed by the incompatibility of restriction enzyme A.
pET costruct:
sites among the three cloning vectors --3" pET, plRES and pCDNA4. W e 6 iX po, i a attempted a strategy in which new BamHI and BstXI restriction sites could "p < N be engineered into the polB insert gene
5.---Nco[--Nd el ---------------------------------------
Notl
by PCR, thus creating a "pol B cassette". This cassette then could be moved easily among various vectors, B.
Pol Pi gene including any we might employ in the
future. However, we were unsuccessful E C in obtaining a full-length polB gene
product using this approach ( Figure 3 4B). A similar differential was observed for MCF-1OAT cells. In -[ ~ our proposal evaluation, one reviewer stated concern for our use of bleomycin as a selective agent, as this antibiotic is known to cause DNA damage and may elevate our mutation frequencies, thus complicating our data analyses. Thus, we used the pIRES vector system, but as will be shown below, the highly toxic nature
Nys i Scm of puromycin also introduced an unexpected variable into our experiments.
B.3. Optimization of cell transfection
We determined that the passage introducing DNA into the cells.
Growth factor and serum depleted +
Electroporation of the DNA was more efficient than lipofection using 4.pRES +++ ++++ lipofectin reagent from several plRES WTpolB ++ ++ commercial sources. Interestingly, the opposite was observed for the transformed MCF-1OAT cells, for which lipofection was more efficient than electroporation ( Table 1) . Other experimental procedures, such as serum starvation or growth factor deprivation, failed to positively impact transfection efficiency for either cell line (Table 1) . Finally, we observed a difference in the recovery of puromycin-resistant, stable transfectants when using the parent pIRES vector versus the pIRES WTpol1 vector. The loss of proliferative potential when polB is overexpressed in MCF1OA/AT cells is further addressed in subsequent sections of this report.
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1.C. Measure levels of po1B protein expression by Western analyses.
Western analyses were performed using anti-
MCF-10A MCF-10AT
pol3 antibody (NeoMarkers) and cell extracts from was readily detected in all samples. However, no S~protein was detected using the same samples and . We were unsuccessful in isolating stable transfectants overexpressing the Y265W/polB variant.
1.D. Characterization of poIB-overexpressing cell lines.
We consistently observed that MCF-1OA cells overexpressing WTpoll3 failed to proliferate as cell populations after two passages post-transfection. The MCF-1OAT/WTpolB population also lost viability, albeit at a later passage. This failure was not observed in the pIRES vector transfected controls, indicating that the loss of proliferative potential is a result of polB overexpression. Viability was maintained in early and mid passages of WTpolB-overexpressing cell populations ( 
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Final Report 2004 K.A. Eckert, Principal Investigator CHO cells (Canitro et al, 1998 ) and h-TERT immortalized human fibroblasts (Yamada and Farber, 2002) results in genetic instability; no loss of proliferative potential was noted in these papers. In a recent publication, however, Fotiadou et al (2004) describe teleomere dysfunction produced by overexpression of pol B in a non-transformed murine mammary cell line. These investigators also describe the production of giant cells and loss of proliferative potential.
Task 2: Qnlantitation of i ISV-tk mutation rates in control and pollt-overexpressing MCF cell lines. The oriP-tk shuttle vector pJY 102 was constructed previously for use in epithelial cell lines. This vector contains the oriP and EBNA-1 sequences from Epstein-Barr virus for episomal replication in epithelial cells; the hygromycin resistance gene for selection of vector-containing human cells; and the thymidine kinase gene from Herpes simplex virus type 1 for mutational analyses. In our proposal, we intended to use the pJY102 vector to quantitate the HSV-tk mutation rate in polB-overexpressing cell populations 30 and 60 passages post-transfection. The observed loss of proliferative potential in MCF1OA and MCF1OAT cells expressing WTpolB precluded our ability to perform these mutational analyses.
Task 3: Determine in vitro transformation properties of" pol11 overexpressing cell populations
We proposed to determine the extent of growth factor independence and the efficiency of anchorage-independent growth in polB expressing cell populations after -30 and -60 passages. The lack of cell proliferation after 3-4 passages required us to undertake an alternative strategy to characterize the cell populations.
A. Molecular changes in transfected cell populations
We analyzed the degree to which puromycin selection and pol3 overexpression altered MCF-1OA and MCF-I OAT cells by Western analyses of a variety of molecular markers. A portion of these analyses are displayed in Figure 8 and summarized in Table 2 . For all cases, we analyzed adherent cell populations three passages post-transfection. Together. these data suggest that puromycin 10AT transfected cell populations.
A. 1. Effects ofpuromycin_(parental cells versus vector-only transformants
selection has altered cell cycle checkpoints and mitogenic signalling in the target cells. increase in MSH2 protein level (4.2-fold) was observed in polB overexpressing MCF-1OA cells, relative to the vector control, but no such change was observed in MCF-1OAT cells (Table 2 ). This result may be due to cellular compensation for an increased number of DNA mismatches caused by polB. No changes in RAD50 levels were observed for either cell line. RCC-1 is a chromatin-associated protein implicated in nuclear formation, nuclear transport, transcription and DNA replication.
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A.3. -Increased apoptosis in polfl-overexpressing cells. Western analyses revealed alterations in pro and
anti-apoptotic proteins in polB overexpressing cell populations. We can detect no anti-apoptotic Bcl-2 protein in any of the MCF1OA cell lines, while the pro-apoptotic Bax protein is increased four-fold in MCF-1OA cells expressing WTpolB, relative to vector controls (Fig.8) . Unlike MCF-1OA cells, MCF-1OAT cells constitutively express detectable levels of Bcl-2 protein. The levels of Bax protein are also increased in the MCF-1OAT/poll overexpressing cells. The net effect is the alteration of the Bax:Bcl-2 ratio in polB overexpressing cells to favor the pro-apoptotic Bax.
We performed functional studies using the AnnexinV marker to confirm that these molecular changes result in the induction of apoptosis in polB overexpressing cell populations. We observed an elevated proportion of early apoptotic cells in polf3-overexpressing MCF1OA and AT cells, relative to the vector controls, and the proportion increased with passage number ( Figure 9A ). The MCF-1OA cell line is more sensitive to the effects of polB overexpression than the MCF-OAT cell line, as demonstrated by the high number of late apoptotic/dead cells in this population at early passage ( Figure 9B ). 3. B. Effects of polB-overexpression on MNU cytotoxicity. We tested whether increased levels of polB affect the efficiency of BER by measuring killing of MCF-IOA/AT populations by N-methyl-Nnitrosourea (MNU). Repair of cytotoxic 0 6 -methylguanine lesions can also be mediated by mismatch repair. We previously reported increased levels of MSH2 in pol3 over-expressing cells. We did not observe a significant change in the MNU cytotoxicity curves for either cell population (figure 10). We conclude that polB overexpression neither enhances nor interferes with BER in MCFIOA/AT cells. 
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Final Report 2004 K.A. Eckert, Principal Investigator Task 4: Qanlil lie mniammary tumor incidence and laItency in control anId t)olil-overexprcssing NI( '-10A/AT cell lines.
4.A. Tumor incidence and characterization
Early passage, puromycin-selected cell populations were used for the tumorigenicity experiments. Cells were injected into the mammary fat pad of nude mice, and the formation of tumors monitored over several months. Parental (unselected) MCF-lOA cells did not form tumors, while we observed an overall tumor incidence of 38% for the ras-transformed MCFI0AT parental cell line (Table 3) . MCF-1OAT cells are reported to be tumorigenic; intriguingly, our cell line appeared to lose its tumorigenic potential with time in culture, as the absolute incidence varied from 80% to 8% from 2001 to 2003. The MCF-1OAT tumors arose beginning 50 days after mammary fat pad injection, and ranged in size from 6-17 mm in diameter at time of removal or sacrifice. In three independent experiments, we observed one or no tumors produced by MCF1OAT cells transfected with the pIRES vector only control (Table 3 ). This suppression is likely due to the observed molecular changes induced by puromycin, such as increased p53 and p21 levels (Figure 8 ).
Tumors were observed after injection of both MCF0OA/polB and MCF-0OAT/polB overexpressing cells. We observed three small (5-6 mm) tumors arising from MCFIOA/polB, corresponding to an incidence of 12% ; we observed on overall 31% incidence of tumors after injection of MCF I OAT/ po•B cells ( Figure 12 and Table 3 ). The MCF1OAT/polB tumors arose with a latency period similar to that of the parental cells, but were smaller than those observed in the parental controls. Histologically, the MCF-OAT parental tumors were solid and displayed infiltration of the stromal layer ( Figure 11 ). In contrast, The tumors arising in both the MCF-1OA/polB and MCF-IOAT/WTpolB groups were fluid filled and less solid than those arising from the MCF-IOAT parental cells (Figure 13 ). The tumors were encapsulated, with well-defined boundaries, and the MCF-10 cells were arranged in defined islands within the stroma. In some tumors, we observed extensive lymphocytic infiltration. These images demonstrate that the tumors formed after puromycin selection and overexpression of polB differ from those formed by the parental cells. 
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4.B. Molecular characterization of mammary tumors
Lysates were prepared from mammary tumors of each group, and analyzed for expression of the exogenous polB using an anti-His antibody (see Figure 3) . Endogenous polB was detected in most samples; however, the his-tagged polB protein is either absent or below detection in all lysates ( Figure  14) . This result raises the possibility the tumors in Figure 13 resulted from outgrowth/selection of MCF1OA/AT cells that lost polB expression after injection. In addition to frozen tissue specimens, paraffin-embedded sections were used for immunohistochemal analyses of polB expression in the tumors. Consistent with the Western analyses, we did not observe consistent, differential polB staining in tumors from MCF-OAT parental versus MCFIOAT/polB cells (Figure 15 ). In some MCF-10AT/polB tumor sections, we did observe intense polB staining in isolated islands of cells (Fig. 15, panel E) . We also observed increased staining of endothelial cells and infiltrating cells (panels C and F). We conclude that a low percentage of MCF1OA/AT-polB cells retain ectopic polB expression in the tumors, but the majority of cells no longer overexpress pol B.
(t-pol beta (--his 
SMCF-1oAT
A K .. We observed lung metastases in 2 of 3 tumor-bearing mice derived from MCF-0 OAT/WTpolB expressing cells. The tumors were too small to collect for further experimental examination. Thus, we have insufficient data to conclude whether these metastases were spontaneous or were induced by polBoverexpression. 
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Conclusions
We have observed that overexpression of DNA polymerase B in diploid, human breast epithelial cell lines, MCF-1OA and MCF-10AT, results in loss of proliferative potential, through the induction of apoptosis. The response may, in part, result from the antibiotic (puromycin) used for selection of the transfected cells. The ras-transformed MCF-OAT cell line appears to be somewhat more tolerant of polg overexpression. Polf overexpression in MCF-0OA/AT cells increases the number of apoptotic cells within the population and may alter the control of apoptosis, as evidenced by aberrant ratios of pro-and anti-apoptotic protein levels. This apoptotic response may be due to the dysregulation of telomere maintenance that has been reported to result from polg overexpression in murine mammary cells (Fotiadou et al, 2004) .
Pol8 overexpression in MCF-1OA cells resulted in a low incidence of tumors (12%), whereas no tumors were observed from the parental cell line. The tumors arising from MCF1OAT cells overexpressing polB displayed a reduced incidence (14%) relative the parental cells (38%), but an increased incidence relative to the vector control cells (4.8%). The suppression of MCF1OAT cell tumorigenicity in the vector transfected controls is likely due to the observed molecular alterations in cell cycle progression proteins induced by puromycin selection. The tumors produced by polB-overexpressing cells displayed an altered histology, relative to the MCF-1OAT parental tumors. These tumors were cyst-like rather than solid, displaying lympocyte infiltration in some cases. Two animals bearing MCF-IOAT/polB tumors progressed to form lung metastases. Molecular analyses of tumor lysates arising from the MCF-10AT/WTpol8 cells demonstrated that exogenous polB protein expression was diminished or lost in the tumor populations. Immunohistochemical analyses indicate that polB overexpression may be retained in isolated islands of cells within the tumor. These observations suggest that biologic selection occurred within the animal for a MCF-1 OAT/WTpolB cell variants that have lost polB overexpression. We propose that polB overexpression induces genomic instability in MCF-I OA and MCF-1 OAT cells, and that these genomic alterations (presumably chromosome aberrations) result primarily in cell death. In rare cells, or within the host environment of the mammary fat pad, variants are selected that have the potential to proliferate for an extended period of time, allowing for additional genetic changes and neoplastic progression.
